A motion to throw out ESOP allegations against Stiefel Laboratories Inc. has been granted relative to three plaintiffs' claims and denied relative to a fourth's by a federal court in Atlanta.
SLI was a privately held pharmaceutical company until July 2009, when GlaxoSmithKline bought it.
In 1975 the family-owned company established a defined contribution plan that incorporated shares of company stock in separate accounts for employees, which they could sell to the company at a qualifying event, like retirement, or the death of a family member.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.